HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yali Dou Selected Research

Sepsis (Septicemia)

4/2010Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis.
2/2008Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yali Dou Research Topics

Disease

21Neoplasms (Cancer)
11/2023 - 01/2005
18Leukemia
01/2021 - 01/2005
3Neoplasm Metastasis (Metastasis)
08/2023 - 01/2022
3Breast Neoplasms (Breast Cancer)
01/2022 - 05/2013
2Neurodevelopmental Disorders
09/2023 - 01/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2023 - 01/2022
2Ovarian Neoplasms (Ovarian Cancer)
05/2016 - 11/2015
2Colonic Neoplasms (Colon Cancer)
01/2016 - 05/2014
2Carcinogenesis
06/2015 - 05/2013
2Sepsis (Septicemia)
04/2010 - 02/2008
1Carcinoma (Carcinomatosis)
11/2022
1Adenocarcinoma
01/2022
1Pneumonia (Pneumonitis)
01/2021
1COVID-19
01/2021
1Cytokine Release Syndrome
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Fatty Liver
01/2021
1Genetic Translocation (Chromosomal Translocation)
03/2020
1Heart Failure
01/2020
1Non-alcoholic Fatty Liver Disease
01/2020
1Fatigue
01/2019
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
01/2018
1Aplastic Anemia (Anemia, Hypoplastic)
01/2018
1Triple Negative Breast Neoplasms
01/2017
1Primitive Neuroectodermal Tumors (PNET)
11/2016
1Retinoblastoma (Glioblastoma, Retinal)
11/2015
1Colorectal Neoplasms (Colorectal Cancer)
05/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2013
1Lymphoma (Lymphomas)
05/2013
1Renal Cell Carcinoma (Grawitz Tumor)
05/2013
1Peritonitis
02/2008

Drug/Important Bio-Agent (IBA)

14MethyltransferasesIBA
09/2023 - 10/2005
13Histones (Histone)IBA
06/2020 - 10/2005
10Proteins (Proteins, Gene)FDA Link
06/2020 - 01/2005
8Histone MethyltransferasesIBA
11/2023 - 01/2005
7Lysine (L-Lysine)FDA Link
06/2020 - 07/2010
5EnzymesIBA
09/2023 - 11/2016
3PeptidomimeticsIBA
01/2019 - 01/2017
2ChromatinIBA
11/2023 - 01/2020
2activin AIBA
08/2023 - 01/2022
2Activins (Activin)IBA
08/2023 - 01/2022
2Histone DemethylasesIBA
01/2022 - 01/2016
2LipidsIBA
01/2021 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 11/2016
2MM-401IBA
01/2017 - 01/2014
2ChemokinesIBA
01/2016 - 11/2015
2Transcription Factors (Transcription Factor)IBA
12/2011 - 10/2006
1p38 Mitogen-Activated Protein KinasesIBA
08/2023
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
11/2022
1MTOR InhibitorsIBA
01/2022
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2021
1Aminobutyrates (Aminobutyric Acid)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Etanercept (Enbrel)FDA Link
01/2021
1BaclofenFDA LinkGeneric
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2020
1Apolipoproteins B (ApoB)IBA
01/2020
1phospholambanIBA
01/2020
1NucleophosminIBA
01/2020
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2018
1Oncogene Proteins (Oncogene Protein)IBA
01/2018
1telomerase RNA (bTR)IBA
01/2018
1compound 18IBA
01/2017
1Intrinsically Disordered ProteinsIBA
01/2017
1Hematoxylin (Haematoxylon)IBA
11/2016
1Formaldehyde (Formol)FDA Link
11/2016
1Eosine Yellowish-(YS) (Eosin)IBA
11/2016
1ParaffinIBA
11/2016
1PlatinumIBA
05/2016
1Polycomb Repressive Complex 2IBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
11/2015
1Retinaldehyde (Retinal)IBA
11/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2014
1LigandsIBA
05/2014
1Chemokine ReceptorsIBA
05/2014
1Interleukin-22 (IL-22)IBA
05/2014
1Messenger RNA (mRNA)IBA
05/2013
1Immunoglobulins (Immunoglobulin)IBA
05/2013
1Peptides (Polypeptides)IBA
07/2010
1salicylhydroxamic acid (SHAM)IBA
06/2010
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
10/2006
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2005

Therapy/Procedure

7Therapeutics
01/2022 - 06/2015
4Immunotherapy
01/2020 - 11/2015
2Punctures
04/2010 - 02/2008
2Ligation
04/2010 - 02/2008
1Drug Therapy (Chemotherapy)
05/2016
1Molecular Targeted Therapy
11/2015